Literature DB >> 3957458

Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma.

J ten Kate, H F van den Ingh, P M Khan, F T Bosman.   

Abstract

Immunoreactive adenosine deaminase complexing protein (ADCP) was studied in 91 human colorectal adenocarcinomas. The expression of ADCP was correlated with that of secretory component (SC) and carcinoembryonic antigen (CEA), with the histological grade and the Dukes' stage of the carcinomas. The histological grade was scored semi-quantitatively according to 5 structural and 4 cytological variables. ADCP expression was observed in 3 different staining patterns, namely: (1) diffuse cytoplasmic (77% of the carcinomas); (2) granular cytoplasmic (13%); and (3) membrane-associated (66%). These patterns were observed alone or in combination. Eleven percent of the carcinomas exhibited no ADCP immunoreactivity. Linear regression analysis showed that the expression of ADCP correlates with that of SC and CEA. However, no significant correlation emerged between the histological parameters or the Dukes' stage and any of the immunohistological parameters. Comparison of the histological characteristics of carcinomas exhibiting little or no ADCP immunoreactivity with those showing extensive immunoreactivity, showed that membranous ADCP immunoreactivity occurs more frequently in well-differentiated carcinomas. Structural parameters showed a better correlation with membranous ADCP expression than the cytological variables. It is concluded that membranous expression of ADCP and CEA are indicators of a high level of differentiation as reflected primarily in the structural characteristics of the tumor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957458     DOI: 10.1002/ijc.2910370402

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.

Authors:  Pei-Jun Liu; Chi-De Chen; Chih-Liang Wang; Yi-Cheng Wu; Chia-Wei Hsu; Chien-Wei Lee; Lien-Hung Huang; Jau-Song Yu; Yu-Sun Chang; Chih-Ching Wu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2015-01-31       Impact factor: 5.911

2.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

3.  Serum Adenosine Deaminase Levels and Human Papillomavirus as Prognostic and Predictive Factors for Laryngeal and Pharyngeal Carcinomas.

Authors:  C Chandrakiran; Thanu Jogy; Sanjay B Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-30

4.  Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.

Authors:  Ernest Y Tan; Michelle Mujoomdar; Jonathan Blay
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

5.  A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.

Authors:  U V Wesley; A P Albino; S Tiwari; A N Houghton
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

6.  Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.

Authors:  O J Cordero; D Ayude; M Nogueira; F J Rodriguez-Berrocal; M P de la Cadena
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

7.  Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.

Authors:  A N Houghton; A P Albino; C Cordon-Cardo; L J Davis; M Eisinger
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

8.  Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.

Authors:  Heae Surng Park; Hyun Yang Yeo; Hee Jin Chang; Kyung-Hee Kim; Ji Won Park; Byung Chang Kim; Ji Yeon Baek; Sun Young Kim; Dae Yong Kim
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

9.  Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.

Authors:  Loretta De Chiara; Ana M Rodríguez-Piñeiro; Oscar J Cordero; Lidia Vázquez-Tuñas; Daniel Ayude; Francisco J Rodríguez-Berrocal; María Páez de la Cadena
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

Review 10.  Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma.

Authors:  Thomas Bogenrieder; Meenhard Herlyn
Journal:  Crit Rev Oncol Hematol       Date:  2002-10       Impact factor: 6.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.